In vitro studies in lymphoma, leukemia, glioblastoma, colorectal cancer have shown ONC201 increases apoptosis and inhibits AKT/mTOR signaling, leading to a corresponding decrease in tumor growth in mouse models [17, 19]. This evidence concerns the gene MTOR and neoplasm.